NOD mice are defective in proteasome production and activation of NF-κB

Molecular and Cellular Biology

Volumn 19, Issue 12, 1999, Pages 8646-8659

  Hayashi, Takuma ^a   Faustman, Denise ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; ENZYME SYNTHESIS; GENE EXPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SPLEEN CELL;

ANIMALIA;

EID: 0033499621     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.12.8646     Document Type: Article

References (94)

1. Akiyama, K. Y., K. Yokota, S. Kagawa, N. Shimbara, T. Tamura, H. Akioka, H. G. Nothwang, C. Noda, K. Tanaka, and A. Ichihara. 1994. cDNA cloning and interferon γ down-regulation of proteasomal subunits X and Y. Science 265:1231-1234.
2. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5:601-604.
3. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 12:141-179.
4. Baltimore, D. 1996. NF-κB: ten years after. Cell 87:13-20.
5. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
6. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the re1A component of NF-κB. Nature 376:167-170.
7. Belich, M. P., R. J. Glynne, G. Senger, D. Sheer, and J. Trowsdale. 1994. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 4:769-776.
8. Belich, M. P., A. Salmeron, L. T. Johnston, and S. C. Ley. 1999. TPL-2 kinase regulates the proteolysis of the NF-κB inhibitory protein NF-κB1p105. Nature 397:363-368.
9. Bohnlein, E., J. W. Lowenthal, M. Siekevitz, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear protein regulates mitogen activation of both the interleukin-2 receptor-α gene and type 1 HIV. Cell 53:827-836.
10. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373:531-536.
11. Bushdid, P. B., D. M. Brantley, F. E. Yull, G. L. Blaeuer, L. H. Hoffman, L. Niswander, and L. D. Kerr. 1998. Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aderrant limb morphogenesis. Nature 392:615-618.
12. Caamano, J. H., C. A. Rizzo, S. K. Durham, D. S. Barton, C. Raventos-Suarez, C. M. Snapper, and R. Bravo. 1998. Nuclear factor (NF)-κB2 (p100/ p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185-196.
13. Coux, O., and A. L. Goldberg. 1998. Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor κB1. J. Biol. Chem. 273:8820-8828.
14. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
15. Crisa, L., J. P. Mordes, and A. A. Rossini. 1992. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab. Rev. 8:9-37.
16. Cross, S. L., N. F. Halden, M. Lenardo, and W. J. Leonard. 1989. Functionally distinct NF-κB binding sites in the immunoglobulin-κ and IL-2 receptor α chain genes. Science 244:466-468.
17. Cui, H., K. Matusi, S. Omura, S. L. Schaver, R. A. Matulka, G. E. Sonensheln, and S. T. Ju. 1997. Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 94:7515-7520.
18. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
19. Fan, C. M., and T. Maniatis. 1991. Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354:395-398.
20. Faustman, D., G. Eisenbarth, J. Daley, and J. Breitmeyer. 1989. Abnormal T lymphocyte subsets in type I diabetes mellitus: analysis with anti-2H4 and anti-4B4 antibodies. Diabetes 38:1462-1468.
21. Faustman, D., X. Li, H. Y. Lin, Y. Fu, G. Eisenbarth, J. Avruch, and J. Guo. 1991. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 254:1756-1761.
22. Faustman, D. L. 1993. Occult CD45 T cell developmental defect in type I diabetes. Diabetes Metab. 19:446-457.
23. Faustman, D. L. Unpublished observation.
24. Foulis, A. K. 1987. C. L. Oakley Lecture 1987. The pathogenesis of β cell destruction in type I (insulin-dependent) diabetes mellitus. J. Pathol. 152: 141-148.
25. Franzo, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist, 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:3482-3496.
26. Freland, S., B. J. Chambers, M. Andersson, L. Van Kaer, and H. G. Ljunggren. 1998. Rejection of allogenic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. J. Immunol. z160:572-579.
27. Fruh, K., Y. Yang, D. Arnold, J. Chambers, L. Wu, J. B. Waters, T. Spies, and P. A. Peterson. 1992. Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J. Biol. Chem. 267:22131-22140.
28. Fu, Y., D. M. Nathan, F. Li, X. Li, and D. L. Faustman. 1993. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J. Clin. Investig. 91:2301-2307.
29. Fu, Y., G. Yan, L. Shi, and D. Faustman. 1998. Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann. N.Y. Acad. Sci. 842:138-155.
30. Gaczynska, M., A. L. Goldberg, K. Tanaka, K. B. Hendil, and K. L. Rock. 1996. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J. Biol. Chem. 271:17275-17280.
31. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682.
32. Goldberg, A. L. 1995. Functions of the proteasome: the lysis at the end of the tunnel. Science 268:522-523.
33. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. Van Kaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J. Exp. Med. 187:97-104.
34. Hanafusa, T., A. Miyazaki, J. Miyagawa, S. Tamura, M. Inada, K. Yamada, Y. Shinji, H. Katsura, K. Yamagata, and N. Itoh. 1990. Examination of islets in the pancreas biopsy specimens from newly diagnosed type I (insulin-dependent) diabetic patients. Diabetologia 33:105-111.
35. Hayashi, T., and D. Faustman. Unpublished data.
36. Hayashi, T., T. Sekine, and T. Okamoto. 1993. Identification of a new serine kinase that activates NF-κB by direct phosphorylation. J. Biol. Chem. 268: 26790-26795.
37. Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxireductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380-11388.
38. Hisamatsu, H., N. Shimbara, Y. Saito, P. Kristensen, K. B. Hendil, T. Fujiwara, E. Takahashi, N. Tanahashi, T. Tamura, A. Ichihara, and K. Tanaka. 1996. Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. J. Exp. Med. 183:1807-1816.
39. Horwitz, B. H., M. L. Scott, S. R. Cherry, R. T. Bronson, and D. Baltimore. 1997. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity 6:765-772.
40. Hu, Y., V. Baud, M. Delhase, P. Zhang, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284:316-320.
41. Iotsova, V., J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3:1285-1289.
42. Jansen, A., M. Van Hagen, and H. A. Drexhage. 1995. Defective maturation and function of antigen-presenting cells in type I diabetes. Lancet 345:491-492.
43. Kanegae, Y., A. T. Tavares, J. C. I. Belmonte, and I. M. Verma. 1998. Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature 392:611-614.
44. Kay, T. W. H., I. L. Campbell, L. Oxbrow, and L. C. Harrison. 1991. Overexpression of class I major histocompatibility complex accompanies insulitis in the nonobese diabetic mouse and is prevented by anti-interferon-γ antibody. Diabetologia 34:779-785.
45. Kishi, F., Y. Suminami, and J. J. Monaco. 1993. Genomic organization of the mouse Lmp2 gene and characteristic structure of its promoter. Gene 133: 243-248.
46. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
47. Li, F., J. Guo, Y. Fu, G. Van, and D. Faustman. 1994. Abnormal class I assembly and peptide presentation in the diabetic NOD mouse. Proc. Natl. Acad. Sci. USA 91:11128-11132.
48. Li, F., S. L. Hauser, M. J. Linan, M. C. Stein, and D. L. Faustman. 1995. Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes. Ann. Neurol. 38:147-154.
49. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321-325.
50. Li, Q., Q. Lu, J. Y. Hwang, D. Buscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. Ikk1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
51. Li, X., and D. Faustman. 1993. Use of donor β2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation 55:940-946.
52. Lin, L., G. N. DeMartino, and W. C. Greene. 1998. Co-translational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92:819-828.
53. MacKichan, M. L., F. Logeat, and A. Israel. 1996. Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing of p50 NF-κB. J. Biol. Chem. 271:6084-6091.
54. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1-13.
55. Maniatis, T. 1999. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 13:505-510.
56. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
57. Naumann, N., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607.
58. Neri, A., C. C. Chang, L. Lombardi, M. Salina, P. Corrandini, A. T. Maiolo, R. S. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
59. Ono, S. J., B. Issa-Chergui, E. Colle, R. D. Guttmann, T. A. Seemayer, and A. Fuks. 1988. IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 37:1411-1418.
60. Orian, A., S. Whiteside, A. Israel, I. Stancovski, A. L. Schwartz, and A. Ciechanover. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. J. Biol. Chem. 270:21707-21714.
61. Ouaaz, F., M. Li, and A. A. Beg. 1999. A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death. J. Exp. Med. 189:999-1004.
62. Pahl, H. L., and P. A. Baeuerle. 1996. Control of gene expression by proteolysis. Curr. Opin. Cell Biol. 8:340-347.
63. Palombella, V., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
64. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1999. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-792.
65. Rabinovitch, A., and J. S. Skyler. 1998. Prevention of type 1 diabetes. Med. Clin. N. Am. 82:739-755.
66. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
67. Reimers, J. I., A. K. Rasmussen, A. E. Karlsen, U. Bjerre, H. Liang, O. Morin, H. U. Andersen, T. Mandrup-Poulsen, A. G. Burger, U. Feldt-Rasmussen, and J. Nerup. 1996. Interleukin-1 β inhibits rat thyroid cell function in vivo and in vitro by a NOD-independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB rats. J. Endocrinol. 151:147-157.
68. + B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects. Diabetes 40:1314-1318.
69. Schmid, R. M., N. D. Perkins, C. S. Duckett, P. C. Andrews, and G. J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736.
70. Sears, C., J. Olesen, D. Rubin, D. Finley, and T. Maniatis. 1998. NF-κB p105 processing via the ubiquitin-proteasome pathway. J. Biol. Chem. 273:1409-1419.
71. + T cells in the development of autoimmune diabetes in the nonobese (NOD) mouse. Int. Immunol. 5:479-489.
72. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
73. Smerdon, R. A., M. Peakman, M. J. Hussain, L. Alviggi, P. J. Watkins, D. G. Leslie, and D. Vergami. 1993. Increase in simultaneous coexpression of naïve and memory lymphocyte markers at diagnosis of IDDM. Diabetes 42:127-133.
74. Snapper, C. M., P. Zelazowski, F. R. Rosas, M. R. Kehry, M. Tian, D. Baltimore, and W. C. Sha. 1996. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:183-191.
75. Stephens, L. A., H. E. Thomas, and T. W. Kay. 1997. Protection of NIT-1 pancreatic β-cells from immune attack by inhibition of NF-κB. J. Autoimmun. 10:293-298.
76. Sun, S. C., P. A. Ganchi, C. Beraud, D. W. Ballard, and W. C. Greene. 1994. Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346-1350.
77. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313-316.
78. Tan, T.-H., G. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. L. Longo, and N. R. Rice. 1992. κB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-Rel. Mol. Cell. Biol. 12:4067-4075.
79. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L., Hardy, and D. V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421-429.
80. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
81. Tickle, C. 1998. Worlds in common through NF-κB. Nature 392:547-549.
82. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
83. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP-2 mutant mice. Immuniry 1:533-541.
84. Verma, I. M., J. K. Stevenson, D. V. Schwarz, S. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
85. Verma, I. M., and J. Stevenson. 1997. IκB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94:11758-11760.
86. Vidal-Puig, A., and D. L. Faustman. 1994. Tolerance to peripheral tissue is transient and maintained by tissue specific class I expression. Transplant. Proc. 26:3314-3316.
87. Vives-Pi, M., M. P. Armengol, L. Alcalde, M. Costa, N. Somoza, F. Vargas, D. Jaraquemada, and R. Pujol-Borrell. 1996. Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effects of cytokines and evidence of hyperexpression in IDDM. Diabetes 45:779-788.
88. Vives-Pi, M., F. Vargas, R. F. James, J. Trowsdale, M. Costa, M. Sospedra, N. Somoza, G. Obiols, R. Tampe, and R. Pujol-Borrel. 1997. Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. Tissue Antigens 50:153-163.
89. Wang, C. Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274: 784-787.
90. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
91. Weringer, E. J., and A. A. Like. 1988. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats. Am. J. Pathol. 132:292-303.
92. Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. Fitzgerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682-4690.
93. Yan, G., Y. Fu, and D. L. Faustman. 1997. Reduced expression of Tap1 and Lmp2 antigen processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. J. Immunol. 159:3068-3080.
94. Yang, X. D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schriber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.